Patent details

Basic Information

Publication number:

EP2961383

PCT Application Number:

JP2014055890

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147127930

PCT Publication Number:

WO2014133196

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN

French Title of Invention:

SUSPENSION POUR ADMINISTRATION PAR VOIE ORALE COMPRENANT DU TOLVAPTAN AMORPHE

German Title of Invention:

SUSPENSION ZUR ORALEN VERABREICHUNG MIT AMORPHEM TOLVAPTAN

SPC Number:

Dates

Filing date:

28/02/2014

Grant date:

27/02/2019

EP Publication Date:

06/01/2016

PCT Publication Date:

04/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/02/2019

EP B1 Publication Date:

27/02/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

28/02/2019

Expiration date:

28/02/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/02/2019

 

 

Name:

Otsuka Pharmaceutical Co., Ltd.

Address:

9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, Tokyo 101-8535, Japan (JP)

Inventor

1

Name:

NISHIBAYASHI, Toru

Address:

Japan (JP)

2

Name:

AKAGI, Akitsuna

Address:

Japan (JP)

3

Name:

NAKAMURA, Atsuya

Address:

Japan (JP)

4

Name:

SUZUKI, Kai

Address:

Japan (JP)

Priority

Priority Number:

2013041105

Priority Date:

01/03/2013

Priority Country:

Japan (JP)

Classification

IPC classification:

A61K 9/08; A61K 9/16; A61K 31/55; A61K 47/26; A61K 47/38;

Publication

European Patent Bulletin

Issue number:

201909

Publication date:

27/02/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages